PFAS Study Finds Higher Levels in Younger Veterans
Analysis based on 10 articles · First reported Sep 14, 2026 · Last updated Sep 21, 2026
The study is unlikely to move broad equity markets directly, but it raises the prospect of expanded PFAS testing coverage, cleanup liabilities, and regulatory scrutiny that could affect chemical manufacturers, defense contractors, and healthcare providers over time. Investor attention may focus on companies exposed to PFAS litigation and remediation costs, as well as on potential federal spending on testing and cleanup at military installations.
A peer-reviewed study led by researchers from Brown University and Harvard University, published in the journal Environmental Health Perspectives, found that United States military veterans have higher blood concentrations of per- and polyfluoroalkyl substances (PFAS), commonly called forever chemicals, than civilians of similar ages. The study analyzed 15 years of data from the United States — Centers for Disease Control and Prevention National Health and Nutrition Examination Survey, covering survey cycles from 2003 to 2018 and representing an estimated 22.8 million U.S. adults with prior military service. Approximately 58% of all veterans exceeded the 20 nanograms per milliliter threshold recommended for medical follow-up by the National Academies of Sciences, Engineering, and Medicine, versus 36% of civilians. The sharpest difference appeared among veterans aged 20 to 39, whose PFAS concentrations were 13% to 24% higher than non-veteran peers, with 52% exceeding the threshold compared with 30% of civilians. Lead author Christian Erbe recommended that male veterans aged 20 to 39 speak with a physician about PFAS blood testing and related health screening. Co-author Joseph Braun attributed the age pattern to recent acute exposure during military work and training, plus the slow excretion of PFAS over time. The study noted that PFAS sources may include firefighting foams, munitions, and groundwater contamination at military installations. The United States — United States Department of Defense has spent more than $2 billion since 2017 on inspections and cleanup at over 700 installations with known or suspected PFAS releases, according to the United States — United States Government Accountability Office, and plans to phase out AFFF firefighting foam fleet-wide by October 2027 after twice delaying the original deadline. The United States — United States Department of Veterans Affairs does not currently cover PFAS blood tests, though a spokesperson said physicians can order testing through commercial labs when deemed medically necessary. Hoover urged the VA to expand testing, calling the coverage gap an enormous oversight. The World Health Organization classifies PFAS as having sufficient evidence of cancer in lab animals and limited evidence linking PFOA to testicular and kidney cancer. The study was supported by grants from the United States — National Institute of Environmental Health Sciences, with Elizabeth Costello contributing.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard